Clinical Trial Update: Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating docetaxel in combination with St. John's Wort for solid tumors that cannot be removed surgically has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Kidney Cancer
• Lung Cancer
• Prostate Cancer
• Urinary Tract Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• St. John's Wort (Hypericum perforatum)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Adult Solid Tumor, Breast Cancer | Phase 3 | Status: WITHDRAWN